New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA's rising criticism: A response option

With an expanded staff and power, FDA 483 letters are expected to rise. Here's one option on how to avoid and respond to agency criticism.

Hp 19185 I Stock Warning And Risk

CEE Packaging, the Packaging Industry of Central and Eastern Europe, reports that a 10-step guide is available to help pharmaceutical processors, medical device manufacturers, and other life-sciences facilities respond appropriately within the permitted 15-day window of receiving a 483 letter from the agency. The guide, “How to Avoid and Respond to Public FDA Criticisms—Form 483 Letters—for Temperature, Humidity and other Controlled Environments,” comes from Veriteq. provides some basics on FDA-issued warning letters.

Packaging World/Healthcare Packaging legal columnist Eric Greenberg recently discussed the agency's increasing activity. Read more about FDA, regulatory, and legal developments.

-Jim Butschli, Editor

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts